Resources

American Conference Institute’s Summit on U.S. Biosimilars

Speaker
4/22/2015
Sheraton Munich Arabellapark Hotel
Munich,
Germany
This conference provides an up-to-the-moment treatise on the significant regulatory and IP developments affecting US biosimilars. Partner, John Callahan, presenting on "Mastering the Essentials of New USPTO Post-Grant Proceedings For Effective Use in the Biosimilars Space." 

For more on this conference, please click here.